Society for Pediatric Dermatology Poster Presentation: Phase 2a Trial of Topical Therapeutic for Mild, Moderate, and Severe Atopic Dermatitis

Alphyn Logo 1

NEWS PROVIDED BY
Alphyn Biologics
July 13, 2023, 19:30 ET

CONTACTS

 

Corporate:
Neal Koller
nkoller@alphynbiologics.com
(410) 690-8687

 

Media:
Susan Thomas
susan@endpointcommunications.net
(619) 540-9195